XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.31

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (8071)	12/15/1998 10:08:00 PM
From: Bluegreen	Read Replies (1) of 17367

Bob, how many times are you going to go through this type of thing? You have explained events to him in baby steps innumerable times but once again here you are full circle starting all over again. One question, what kind of clinician uses a drug on people in an indiscriminate manner IF it doesn't work? Give me a break! If McCamant, Murphy, Taipan and Prohost say Neuprex might have HUGE potential as antibacterial agent, why argue possible limited sepsis issues? All the arguing in the world is not going to change the fact that the above EXPERT newsletters are screaming BUY Xoma at these levels. All four newsletters saying the same thing at the same time. Now that is what really frustrates people who are slamming Xoma, you might find fault with one or two newsletters but ALL FOUR? I don't think so. These four newsletters think we have a potential winner here and DSMB meets soon. Are you ready?<g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next